New Delhi: The government on Tuesday called for an inter-ministerial meeting to review its preparedness to combat the spread of the swine flu in India.
“The medicine and doctor availability situation was reviewed and the preparedness is complete, especially after the ministry’s experiences during the avain flu,” said an official at the ministry of health and family welfare on condition of anonymity.
The meeting, chaired by Naresh Dayal, secretary, ministry of health, had representatives from the department of pharmaceuticals, ministry of civil aviation, ministry of environment and forests, information and broadcasting as well as the department of biotechnology.
Meanwhile, Hyderabad-based Hetero Pharmaceuticals, which has been licensed by the patent holder Roche Holding AG to manufacture and market antiviral oseltamivir, said it had been contacted by the government. “We received a request asking if we are in a position to supply the drug. We have informed them that we have 100,000 finished packs in stock for supply to India. These had previously been supplied to the government for Rs300 for 10 capsules,” said Srinivas Reddy, director, Hetero Group.
Amar Lulla, joint managing director of Cipla, which also makes antiviral oseltamivir, said “orders from other markets are in the pipeline and the company will start supplying in 405 weeks at $1 per capsule”.